B2m-KO(M-NSG)
品系全名
M-NSG-B2memSmoc
目录号
NM-NSG-002
品系状态
胚胎冻存
基因信息
基因名
B2M
品系描述
验证数据
Fig 1. Expression characterization of mouse MHC I and MHC II in bone marrow, blood, spleen in B2m-KO(NMG) mice.
Fig 2. Body weight growth curve of huPBMC-B2m-KO(NMG) mice.
Fig 3. Survival rate of huPBMC-B2m-KO(NMG) mice.
Fig 4. GvHD scores of huPBMC-B2m-KO(NMG) mice.
Fig 5. Percentage of hCD45-positive cells of huPBMC-B2m-KO(NMG) mice.
Fig 6. Flow analysis of peripheral blood lymphocyte subpopulations in the huPBMC-B2m-KO(NMG) mice.
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
